281 related articles for article (PubMed ID: 38430396)
1. Changes in distinct brain systems identified with fMRI during smoking cessation treatment with varenicline: a review.
Panagopoulos VN; Bailey A; Kostopoulos GK; Ioannides AA
Psychopharmacology (Berl); 2024 Apr; 241(4):653-685. PubMed ID: 38430396
[TBL] [Abstract][Full Text] [Related]
2. Effects of varenicline on smoking cue–triggered neural and craving responses.
Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR
Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958
[TBL] [Abstract][Full Text] [Related]
3. Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review.
Menossi HS; Goudriaan AE; de Azevedo-Marques Périco C; Nicastri S; de Andrade AG; D'Elia G; Li CS; Castaldelli-Maia JM
CNS Drugs; 2013 Nov; 27(11):921-41. PubMed ID: 23853032
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.
Sutherland MT; Carroll AJ; Salmeron BJ; Ross TJ; Hong LE; Stein EA
Biol Psychiatry; 2013 Oct; 74(7):538-46. PubMed ID: 23506999
[TBL] [Abstract][Full Text] [Related]
5. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
[TBL] [Abstract][Full Text] [Related]
6. Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers.
Sutherland MT; Carroll AJ; Salmeron BJ; Ross TJ; Hong LE; Stein EA
Neuroimage; 2013 Feb; 66():585-93. PubMed ID: 23110878
[TBL] [Abstract][Full Text] [Related]
7. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
8. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
9. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
10. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
[TBL] [Abstract][Full Text] [Related]
12. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
Dunn KE; Marcus TF; Kim C; Schroeder JR; Vandrey R; Umbricht A
Nicotine Tob Res; 2016 May; 18(5):1171-9. PubMed ID: 26476459
[TBL] [Abstract][Full Text] [Related]
13. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Keating GM; Lyseng-Williamson KA
Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
[TBL] [Abstract][Full Text] [Related]
14. Altered spontaneous activity of posterior cingulate cortex and superior temporal gyrus are associated with a smoking cessation treatment outcome using varenicline revealed by regional homogeneity.
Wang C; Shen Z; Huang P; Qian W; Yu X; Sun J; Yu H; Yang Y; Zhang M
Brain Imaging Behav; 2017 Jun; 11(3):611-618. PubMed ID: 26960945
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
16. Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers.
Fedota JR; Sutherland MT; Salmeron BJ; Ross TJ; Hong LE; Stein EA
Neuropsychopharmacology; 2015 Jul; 40(8):2038-46. PubMed ID: 25742873
[TBL] [Abstract][Full Text] [Related]
17. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
[TBL] [Abstract][Full Text] [Related]
18. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
19. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
[TBL] [Abstract][Full Text] [Related]
20. The effect of varenicline and nicotine patch on smoking rate and satisfaction with smoking: an examination of the mechanism of action of two pre-quit pharmacotherapies.
Lu W; Chappell K; Walters JAE; Jacobson GA; Patel R; Schüz N; Ferguson SG
Psychopharmacology (Berl); 2017 Jul; 234(13):1969-1976. PubMed ID: 28342090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
